Jean-Pierre Kinet
Amministratore Delegato presso iXLife Capital SAS
Profilo
Jean-Pierre Kinet was the founder of AB Science SA (2001) and Co-Managing Director of ATANIS Biotech AG (2021).
He is currently Chairman of VAXON Biotech SA, Chairman of Pharmafast Bio, Director of Qualyst, Inc., Director of Pharmaleads SA, Trustee of Harvard University, Member-Supervisory Board of EXAIL SAS, Member of National Institutes of Health, Managing Partner of iXLife Capital SAS, Member-Supervisory Board of iXCore SASU, Professor at Harvard Medical School, Member-International Strategic Committee of BioWin ASBL, Member of Académie Royale De Médecine De Belgique, Member-Supervisory Board of iXfund SAS, Manager of JPK Consulting LLC, and Manager of Kinet Life Pharma Management.
His former positions include Chairman of Theravectys SAS, Independent Non-Executive Director of UCB SA, Independent Director of Valerio Therapeutics SA, Independent Director of UCB Pharma SA (France), Director-Immunology & Allergy Laboratory of Beth Israel Deaconess Medical Center, Inc., Independent Director of Genewave SAS, and Principal of National Institute of Allergy & Infectious Diseases.
He holds a doctorate degree from the University of Liege.
Dr. Kinet is also the founder of Astarix.
Posizioni attive di Jean-Pierre Kinet
| Società | Posizione | Inizio |
|---|---|---|
Qualyst, Inc.
 Qualyst, Inc. Medical/Nursing ServicesHealth Services Qualyst Transporter Solutions LLC provides hepatic drug transporter products and contract research services utilizing the patented B-CLEAR technology. The company was founded by Kenneth R. Brouwer, Gary M. Pollack and Dhiren R. Thakker in 2001 and is headquartered Durham, NC. | Direttore/Membro del Consiglio | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 15/09/2010 |
| Harvard Medical School | Corporate Officer/Principal | 16/09/2010 |
BioWin ASBL
 BioWin ASBL Miscellaneous Commercial ServicesCommercial Services BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium. | Corporate Officer/Principal | 16/08/2011 |
VAXON Biotech SA
 VAXON Biotech SA Pharmaceuticals: MajorHealth Technology VAXON Biotech SA develops therapeutic vaccines for the treatment of cancers. It offers treatment for lung, gastric, prostate, breast, renal, liver, and colorectal cancers, using its proprietary technology of optimized cryptic peptides. The firm also provides research and development services. The company was founded by Konstantinos Kosmatopoulos in 2004 and is headquartered in Paris, France. | Presidente | 10/09/2010 |
| Académie Royale De Médecine De Belgique | Corporate Officer/Principal | - |
iXLife Capital SAS
 iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | Amministratore Delegato | 10/10/2015 |
Pharmaleads SA
 Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Direttore/Membro del Consiglio | 01/01/2010 |
EXAIL SAS
 EXAIL SAS Aerospace & DefenseElectronic Technology iXBlue SAS manufactures navigation systems using high-spec fiber-optic gyroscopes. The firm offers surface gyrocompasses, photonic components and modules, motion simulators, stabilized platforms, testing and calibration tables, optical fibers and modulators, surface and unmanned underwater vehicle navigators, and space sensors. The company was founded on September 27, 2000 and is headquartered in Saint-Germain-en-Laye, France. | Direttore/Membro del Consiglio | - |
| ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Precedenti posizioni note di Jean-Pierre Kinet
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░ | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Jean-Pierre Kinet
| University of Liege | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| UCB | Health Technology |
| AB SCIENCE | Health Technology |
| VALERIO THERAPEUTICS | Health Technology |
| Aziende private | 20 |
|---|---|
Qualyst, Inc.
Qualyst, Inc. Medical/Nursing ServicesHealth Services Qualyst Transporter Solutions LLC provides hepatic drug transporter products and contract research services utilizing the patented B-CLEAR technology. The company was founded by Kenneth R. Brouwer, Gary M. Pollack and Dhiren R. Thakker in 2001 and is headquartered Durham, NC. | Health Services |
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Health Technology |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
BioWin ASBL
BioWin ASBL Miscellaneous Commercial ServicesCommercial Services BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium. | Commercial Services |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
UCB Pharma SA (France)
 UCB Pharma SA (France) Pharmaceuticals: MajorHealth Technology Part of UCB SA, UCB Pharma SA (France) specializes in allergic and respiratory diseases and disorders. The company is based in Nanterre, France. | Health Technology |
VAXON Biotech SA
VAXON Biotech SA Pharmaceuticals: MajorHealth Technology VAXON Biotech SA develops therapeutic vaccines for the treatment of cancers. It offers treatment for lung, gastric, prostate, breast, renal, liver, and colorectal cancers, using its proprietary technology of optimized cryptic peptides. The firm also provides research and development services. The company was founded by Konstantinos Kosmatopoulos in 2004 and is headquartered in Paris, France. | Health Technology |
Genewave SAS
 Genewave SAS Medical SpecialtiesHealth Technology Genewave SAS developed, manufactured and marketed microarray instrumentation for the molecular diagnostic and life sciences markets. The company was founded by Claude Weisbuch, Henri Benisty and Francois Vallet in December 2001 and was headquartered in Evry, France. | Health Technology |
| National Institute of Allergy & Infectious Diseases | Government |
| Académie Royale De Médecine De Belgique | |
| Astarix | |
iXLife Capital SAS
iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | Finance |
Pharmaleads SA
Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Health Technology |
EXAIL SAS
EXAIL SAS Aerospace & DefenseElectronic Technology iXBlue SAS manufactures navigation systems using high-spec fiber-optic gyroscopes. The firm offers surface gyrocompasses, photonic components and modules, motion simulators, stabilized platforms, testing and calibration tables, optical fibers and modulators, surface and unmanned underwater vehicle navigators, and space sensors. The company was founded on September 27, 2000 and is headquartered in Saint-Germain-en-Laye, France. | Electronic Technology |
| iXfund SAS | |
| JPK Consulting LLC | |
| Kinet Life Pharma Management | |
| Pharmafast Bio | |
iXCore SASU
 iXCore SASU Investment ManagersFinance iXCore deals with marine, aeronautics, and fund industries. It offers in maritime, land and space industry, biotechnology, and investment. The company was founded on September 21, 2001 and is headquartered in Marly-le-Roi, IF. | Finance |
ATANIS Biotech AG
 ATANIS Biotech AG Miscellaneous Commercial ServicesCommercial Services ATANIS Biotech AG is a company based in Oberkirch, Germany that provides a functional allergy diagnostic screening test. The German company's mission is to revolutionize the way allergies are diagnosed and improve treatment success. The company is driven by scientific excellence and provide a proprietary mast cell line that functions as an ex vivo alternative to in vivo testing. Noemi Bachmeier-Zbären, Jean-Pierre Kinet has been the CEOs since 2021. The company was founded in 2021 by Alexander Eggel, Thomas Kaufmann, Noemi Bachmeier-Zbären, Jean-Pierre Kinet. | Commercial Services |
- Borsa valori
- Insiders
- Jean-Pierre Kinet
